510(k) K102964
K102964 is an FDA 510(k) premarket notification submitted by Grifols USA, Inc. for the device "EU-TTG IGA AND EU-TTG IGG". The FDA issued a decision of Substantially Equivalent on Mar 7, 2011. The device falls under product code MVM (Autoantibodies, Endomysial(Tissue Transglutaminase)), a Class II device regulated under 21 CFR 866.5660. Grifols USA, Inc. has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 7, 2011
- Date Received
- Oct 5, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Autoantibodies, Endomysial(Tissue Transglutaminase)
- Device Class
- Class II
- Regulation Number
- 866.5660
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Grifols USA, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.